Sun Pharma Advanced Research Company Ltd.
•₹ 196.71-1.44%
2026-08-21
PROS
- Company has a good return on equity (ROE) track record: 3 Years ROE 51.9%
- Operating margins have improved to 85.1% from -85.1%
- Company comfortably covers its interest (46.5x coverage)
- Company maintains a comfortable, low leverage position
- Company converts assets efficiently - asset turnover of 1.5x
CONS
- Operating cash flow has been negative in recent years
- Company has a low return on capital employed of -86.8%
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -1.25x)
- Free cash flow has been persistently negative
- Total debt has risen sharply - up 115.4% year on year
- Working capital days have increased from -1770 to 215 days
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | PFOCUS | 279.00 | 187.99 | 21727.79 | 0.00 | -457.78 | -514.43 | 12668.15 | 1196.88 | 2.74 | 23.76 |
| 2. | SAGILITY | 42.46 | 20.02 | 19876.92 | 0.35 | 216.81 | 45.94 | 1963.48 | 27.59 | 13.82 | 22.32 |
| 3. | SYNGENE | 397.10 | 72.53 | 16029.70 | 0.31 | -9.00 | -110.38 | 736.00 | -15.84 | 9.48 | 12.34 |
| 4. | IGIL | 338.55 | 24.00 | 14630.77 | 1.48 | 165.74 | 30.98 | 370.78 | 23.22 | 77.00 | 60.35 |
| 5. | INDGN | 564.25 | 33.91 | 13592.86 | 0.40 | 1162.00 | 898.28 | 10631.00 | 1297.34 | 18.92 | 16.39 |
| 6. | NESCO | 1032.45 | 17.63 | 7274.64 | 0.68 | 93.05 | 5.00 | 251.62 | 31.05 | 19.23 | 46.86 |
| 7. | LEAPIND | 160.55 | 113.45 | 7072.81 | 0.00 | — | — | — | — | 9.32 | — |
| 8. | SPARC | 193.15 | 3.96 | 6268.13 | 0.00 | -20.78 | 59.94 | 39.92 | 314.11 | 163.94 | -85.17 |
| 9. | SMARTWORKS | 500.70 | 205.47 | 5727.06 | 0.00 | 13.15 | 413.27 | 546.25 | 44.05 | 52.26 | 63.33 |
| 10. | LATENTVIEW | 276.50 | 29.28 | 5721.48 | 0.00 | 47.10 | -6.84 | 286.88 | 21.55 | 16.69 | 19.76 |
| 11. | JUSTDIAL | 659.80 | 15.46 | 5611.54 | 0.00 | 115.74 | 38.44 | 270.27 | 16.23 | 12.88 | 26.17 |
| 12. | INDIQUBE | 191.25 | 0.00 | 4054.45 | 0.00 | -23.88 | 35.03 | 422.69 | 36.66 | 54.58 | 61.15 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24 | 21 | 14 | 17 | 17 | 13 | 15 | 27 | 10 | 8 | 8 | 13 | 40 | |
| 126 | 113 | 116 | 122 | 110 | 116 | 89 | 80 | 62 | 74 | 65 | 80 | 84 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 10 | 8 | 6 | 4 | 2 | 0 | 0 | 0 | 9 | 0 | 0 | 2 | 24 |
| Interest | 0 | 0 | 0 | 1 | 1 | 1 | 3 | 5 | 6 | 8 | 9 | 12 | 8 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 |
| -95 | -86 | -100 | -105 | -96 | -107 | -79 | -61 | -52 | -76 | -80 | 1,761 | -21 | |
| Tax % | -0.00% | -0.00% | -0.00% | -0.36% | -0.42% | -0.15% | -0.09% | 1.48% | -0.12% | -0.08% | -0.09% | -0.02% | -0.53% |
| Net Profit | 0 | 0 | 0 | 0 | -96 | -107 | -80 | -60 | -52 | -76 | -80 | 1,761 | -21 |
| -3 | -3 | -3 | -3 | -3 | -3 | -2 | -2 | -2 | -2 | -2 | 54 | -0 | |
| Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 24
- 126
- Operating Profit
- —
- OPM %
- —
- Other Income
- 10
- Interest
- 0
- Depreciation
- 3
- -95
- Tax %
- -0.00%
- Net Profit
- 0
- -3
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 21
- 113
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 0
- Depreciation
- 3
- -86
- Tax %
- -0.00%
- Net Profit
- 0
- -3
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 14
- 116
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 0
- Depreciation
- 3
- -100
- Tax %
- -0.00%
- Net Profit
- 0
- -3
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 17
- 122
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 1
- Depreciation
- 3
- -105
- Tax %
- -0.36%
- Net Profit
- 0
- -3
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 17
- 110
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 1
- Depreciation
- 3
- -96
- Tax %
- -0.42%
- Net Profit
- -96
- -3
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 13
- 116
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 3
- -107
- Tax %
- -0.15%
- Net Profit
- -107
- -3
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 15
- 89
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 3
- Depreciation
- 3
- -79
- Tax %
- -0.09%
- Net Profit
- -80
- -2
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 27
- 80
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 5
- Depreciation
- 3
- -61
- Tax %
- 1.48%
- Net Profit
- -60
- -2
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 10
- 62
- Operating Profit
- —
- OPM %
- —
- Other Income
- 9
- Interest
- 6
- Depreciation
- 3
- -52
- Tax %
- -0.12%
- Net Profit
- -52
- -2
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 8
- 74
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 8
- Depreciation
- 3
- -76
- Tax %
- -0.08%
- Net Profit
- -76
- -2
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 8
- 65
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 9
- Depreciation
- 3
- -80
- Tax %
- -0.09%
- Net Profit
- -80
- -2
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 13
- 80
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 12
- Depreciation
- 2
- 1,761
- Tax %
- -0.02%
- Net Profit
- 1,761
- 54
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 40
- 84
- Operating Profit
- —
- OPM %
- —
- Other Income
- 24
- Interest
- 8
- Depreciation
- 2
- -21
- Tax %
- -0.53%
- Net Profit
- -21
- -0
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|
| 239 | 76 | 72 | 1,879 | 69 | |
| 453 | 478 | 395 | 280 | 303 | |
| Operating Profit | -203 | -373 | -321 | 1,610 | — |
| OPM % | -85 | -493 | -448 | 86 | — |
| Other Income | 11 | 29 | 2 | 11 | 25 |
| Interest | 8 | 2 | 9 | 34 | 36 |
| Depreciation | 12 | 13 | 12 | 10 | 10 |
| -223 | -387 | -343 | 1,553 | 1,584 | |
| Tax % | 0 | -0 | 0 | -0 | -0 |
| Net Profit | -223 | -387 | -343 | 1,553 | 1,584 |
| EPS | -8 | -12 | -11 | 48 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -7 | -12 | -11 | 48 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -7 | -12 | -11 | 48 | — |
Mar 2023
- 239
- 453
- Operating Profit
- -203
- OPM %
- -85
- Other Income
- 11
- Interest
- 8
- Depreciation
- 12
- -223
- Tax %
- 0
- Net Profit
- -223
- EPS
- -8
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -7
Mar 2024
- 76
- 478
- Operating Profit
- -373
- OPM %
- -493
- Other Income
- 29
- Interest
- 2
- Depreciation
- 13
- -387
- Tax %
- -0
- Net Profit
- -387
- EPS
- -12
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -12
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -12
Mar 2025
- 72
- 395
- Operating Profit
- -321
- OPM %
- -448
- Other Income
- 2
- Interest
- 9
- Depreciation
- 12
- -343
- Tax %
- 0
- Net Profit
- -343
- EPS
- -11
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -11
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -11
Mar 2026
- 1,879
- 280
- Operating Profit
- 1,610
- OPM %
- 86
- Other Income
- 11
- Interest
- 34
- Depreciation
- 10
- 1,553
- Tax %
- -0
- Net Profit
- 1,553
- EPS
- 48
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 48
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 48
TTM
- 69
- 303
- Operating Profit
- —
- OPM %
- —
- Other Income
- 25
- Interest
- 36
- Depreciation
- 10
- 1,584
- Tax %
- -0
- Net Profit
- 1,584
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 99%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- -6%
- 5 Years:
- -6%
- 3 Years:
- -4%
- 1 Year:
- 36%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 52%
- Last Year:
- 277%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| LIABILITIES | - | - | - | - |
| Equity Capital | 32 | 32 | 32 | 32 |
| 480 | 93 | -249 | 1,306 | |
| 0 | 47 | 158 | 556 | |
| Trade Payables | 148 | 142 | 114 | 97 |
| 169 | 199 | 278 | 176 | |
| Total Liabilities | 830 | 514 | 333 | 2,169 |
| ASSETS | - | - | - | - |
| 106 | 108 | 99 | 85 | |
| Capital Work in Progress | 2 | 1 | 1 | 0 |
| 291 | 2 | 0 | 0 | |
| 0 | 16 | 16 | 8 | |
| Cash & Bank | 112 | 155 | 2 | 1 |
| 320 | 232 | 216 | 2,073 | |
| Total Assets | 830 | 514 | 333 | 2,169 |
| Total Debt | 0 | 47 | 258 | 556 |
| Net Working Capital | 276 | 4 | -348 | 1,108 |
| Contingent Liabilities | 84 | 84 | 85 | 85 |
| Book Value per Share | 15.80 | 3.88 | -6.68 | 41.25 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 |
| Total Debt | 0 | 47 | 258 | 556 |
| Net Working Capital | 276 | 4 | -348 | 1,108 |
| Contingent Liabilities | 84 | 84 | 85 | 85 |
| Book Value per Share | 15.80 | 3.88 | -6.68 | 41.25 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 |
Mar 2023
- Equity Capital
- 32
- 480
- 0
- Trade Payables
- 148
- 169
- Total Liabilities
- 830
- 106
- Capital Work in Progress
- 2
- 291
- 0
- Cash & Bank
- 112
- 320
- Total Assets
- 830
- Total Debt
- 0
- Net Working Capital
- 276
- Contingent Liabilities
- 84
- Book Value per Share
- 15.80
- Face Value
- 1.00
- Total Debt
- 0
- Net Working Capital
- 276
- Contingent Liabilities
- 84
- Book Value per Share
- 15.80
- Face Value
- 1.00
Mar 2024
- Equity Capital
- 32
- 93
- 47
- Trade Payables
- 142
- 199
- Total Liabilities
- 514
- 108
- Capital Work in Progress
- 1
- 2
- 16
- Cash & Bank
- 155
- 232
- Total Assets
- 514
- Total Debt
- 47
- Net Working Capital
- 4
- Contingent Liabilities
- 84
- Book Value per Share
- 3.88
- Face Value
- 1.00
- Total Debt
- 47
- Net Working Capital
- 4
- Contingent Liabilities
- 84
- Book Value per Share
- 3.88
- Face Value
- 1.00
Mar 2025
- Equity Capital
- 32
- -249
- 158
- Trade Payables
- 114
- 278
- Total Liabilities
- 333
- 99
- Capital Work in Progress
- 1
- 0
- 16
- Cash & Bank
- 2
- 216
- Total Assets
- 333
- Total Debt
- 258
- Net Working Capital
- -348
- Contingent Liabilities
- 85
- Book Value per Share
- -6.68
- Face Value
- 1.00
- Total Debt
- 258
- Net Working Capital
- -348
- Contingent Liabilities
- 85
- Book Value per Share
- -6.68
- Face Value
- 1.00
Mar 2026
- Equity Capital
- 32
- 1,306
- 556
- Trade Payables
- 97
- 176
- Total Liabilities
- 2,169
- 85
- Capital Work in Progress
- 0
- 0
- 8
- Cash & Bank
- 1
- 2,073
- Total Assets
- 2,169
- Total Debt
- 556
- Net Working Capital
- 1,108
- Contingent Liabilities
- 85
- Book Value per Share
- 41.25
- Face Value
- 1.00
- Total Debt
- 556
- Net Working Capital
- 1,108
- Contingent Liabilities
- 85
- Book Value per Share
- 41.25
- Face Value
- 1.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| -69 | -429 | -360 | -239 | |
| Cash from Investing | -548 | 392 | 158 | -23 |
| Cash from Financing | 617 | 42 | 199 | 261 |
| -1 | 5 | -3 | -1 | |
| Free Cash Flow | -69 | -439 | -361 | -239 |
| OCF / Net Profit | 0.31 | 1.11 | 1.05 | -0.15 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 |
| OCF / Net Profit | 0.31 | 1.11 | 1.05 | -0.15 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 |
Mar 2023
- -69
- Cash from Investing
- -548
- Cash from Financing
- 617
- -1
- Free Cash Flow
- -69
- OCF / Net Profit
- 0.31
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.31
- Cumulative 5-Year FCF
- 0
Mar 2024
- -429
- Cash from Investing
- 392
- Cash from Financing
- 42
- 5
- Free Cash Flow
- -439
- OCF / Net Profit
- 1.11
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.11
- Cumulative 5-Year FCF
- 0
Mar 2025
- -360
- Cash from Investing
- 158
- Cash from Financing
- 199
- -3
- Free Cash Flow
- -361
- OCF / Net Profit
- 1.05
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.05
- Cumulative 5-Year FCF
- 0
Mar 2026
- -239
- Cash from Investing
- -23
- Cash from Financing
- 261
- -1
- Free Cash Flow
- -239
- OCF / Net Profit
- -0.15
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.15
- Cumulative 5-Year FCF
- 0
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| PER SHARE | - | - | - | - |
| EPS (₹) | -6.86 | -11.93 | -10.55 | 47.86 |
| Book Value (₹) | 15.80 | 3.88 | -6.68 | 41.25 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | -6.50 | -11.55 | -10.17 | 48.17 |
| PROFITABILITY | - | - | - | - |
| Operating Margin % | -85.09% | -532.26% | -450.27% | 85.08% |
| Net Margin % | -93.22% | -512.56% | -477.26% | 82.65% |
| ROE % | -43.41% | -121.28% | 0.00% | 276.89% |
| ROCE % | -41.91% | -112.35% | -311.92% | 163.94% |
| -26.81% | -57.63% | -80.88% | 124.17% | |
| EFFICIENCY | - | - | - | - |
| Debtor Days | 50 | 117 | 80 | 2 |
| Inventory Days | 0 | 0 | 0 | 0 |
| Payable Days | 0 | 0 | 0 | 0 |
| 50 | 117 | 80 | 2 | |
| FINANCIAL HEALTH | - | - | - | - |
| Debt to Equity (x) | 0.00x | 0.37x | -1.19x | 0.42x |
| Interest Coverage (x) | -28.15x | -227.27x | -36.92x | 46.50x |
| 2.54x | 1.02x | 0.07x | 2.47x | |
| GROWTH | - | - | - | - |
| Revenue Growth % | 0.00% | -68.36% | -5.00% | 2518.47% |
| Operating Profit Growth % | 0.00% | -83.40% | 13.76% | 600.93% |
| Net Profit Growth % | 0.00% | -73.96% | 11.55% | 553.48% |
| 0.00% | -73.96% | 11.55% | 553.48% | |
| VALUATION | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 2.39x |
| P/B (x) | 0.00x | 95.47x | -22.14x | 2.78x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | -31.93x | -15.74x | 2.66x |
Mar 2023
- EPS (₹)
- -6.86
- Book Value (₹)
- 15.80
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -6.50
- Operating Margin %
- -85.09%
- Net Margin %
- -93.22%
- ROE %
- -43.41%
- ROCE %
- -41.91%
- -26.81%
- Debtor Days
- 50
- Inventory Days
- 0
- Payable Days
- 0
- 50
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- -28.15x
- 2.54x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- -11.93
- Book Value (₹)
- 3.88
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -11.55
- Operating Margin %
- -532.26%
- Net Margin %
- -512.56%
- ROE %
- -121.28%
- ROCE %
- -112.35%
- -57.63%
- Debtor Days
- 117
- Inventory Days
- 0
- Payable Days
- 0
- 117
- Debt to Equity (x)
- 0.37x
- Interest Coverage (x)
- -227.27x
- 1.02x
- Revenue Growth %
- -68.36%
- Operating Profit Growth %
- -83.40%
- Net Profit Growth %
- -73.96%
- -73.96%
- P/E (x)
- 0.00x
- P/B (x)
- 95.47x
- Dividend Yield %
- 0.00%
- -31.93x
Mar 2025
- EPS (₹)
- -10.55
- Book Value (₹)
- -6.68
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -10.17
- Operating Margin %
- -450.27%
- Net Margin %
- -477.26%
- ROE %
- 0.00%
- ROCE %
- -311.92%
- -80.88%
- Debtor Days
- 80
- Inventory Days
- 0
- Payable Days
- 0
- 80
- Debt to Equity (x)
- -1.19x
- Interest Coverage (x)
- -36.92x
- 0.07x
- Revenue Growth %
- -5.00%
- Operating Profit Growth %
- 13.76%
- Net Profit Growth %
- 11.55%
- 11.55%
- P/E (x)
- 0.00x
- P/B (x)
- -22.14x
- Dividend Yield %
- 0.00%
- -15.74x
Mar 2026
- EPS (₹)
- 47.86
- Book Value (₹)
- 41.25
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 48.17
- Operating Margin %
- 85.08%
- Net Margin %
- 82.65%
- ROE %
- 276.89%
- ROCE %
- 163.94%
- 124.17%
- Debtor Days
- 2
- Inventory Days
- 0
- Payable Days
- 0
- 2
- Debt to Equity (x)
- 0.42x
- Interest Coverage (x)
- 46.50x
- 2.47x
- Revenue Growth %
- 2518.47%
- Operating Profit Growth %
- 600.93%
- Net Profit Growth %
- 553.48%
- 553.48%
- P/E (x)
- 2.39x
- P/B (x)
- 2.78x
- Dividend Yield %
- 0.00%
- 2.66x
Documents
Announcements
- General Updates
2026-08-13 - Sun Pharma Advanced Research Company Limited has informed the Exchange about Filing of Application for Reclassification with Stock Exchanges
- Copy of Newspaper Publication
2026-08-11 - Sun Pharma Advanced Research Company Limited has informed the Exchange about Copy of Newspaper Publication
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Jan 2026
Dec 2024
Apr 2024